Richard Reschen is a Senior Technology Transfer Manager in the Licencing & Ventures group of Oxford University Innovation (OUI), one of the world’s leading technology transfer organisations, responsible for commercialising novel technologies arising from the world-class research at Oxford University. He is a key member of the Pharma/Biotech team and specialises in commercialising technologies in this sector. Richard has a PhD in Genetics from the University of Cambridge.
British universities are highly regarded for their world-leading biological and medical research output. Exploiting this university innovation is of critical importance in producing the ground-breaking technologies that will revolutionise future clinical practice. This talk will highlight the process, importance and impact of technology transfer from universities and showcase a range of real-world examples (covering both patented and copyrighted technologies) that may lead to benefits in clinical practice.